Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

31.71
Delayed Data
As of Sep 04
 -0.15 / -0.47%
Today’s Change
27.92
Today|||52-Week Range
45.45
-22.41%
Year-to-Date

Today’s Trading

Previous close31.86
Today’s open31.46
Day’s range31.20 - 32.41
Volume542,612
Average volume (3 months)624,136
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)-194.84%
Earnings growth (next 5 years)+37.00%
Revenue growth (last year)+19.34%
P/E ratio131.9
Price/Sales4.33
Price/Book2.46

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...+1.40+3.86%
ZSPHZS Pharma Inc+1.09+2.03%
SRPTSarepta Therapeutics...+0.28+0.84%
PTCTPTC Therapeutics Inc+0.19+0.50%
Data as of 3:59pm ET, 09/04/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$401.5M
Annual profit (last year)$17.7M
Net profit margin4.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts

Partner Offers